Medicare

Millions of Medicare enrollees who buy stand-alone prescription drug plans will see their average monthly premiums rise by 50% in 2027, a new analysis finds. But enrollees can avoid the average increase — from $34 a month to $51 — by switching to lower-cost plans during the program’s open enrollment period, which runs through Dec.

Jude Pare and his partner, Diane Tix, live in rural Minnesota until temperatures dip below freezing, when they take refuge in Arizona for the winter. While away, their mail is forwarded. But Pare, 77, said he didn’t receive any warning from his Medicare prescription drug plan that his $0 monthly premium was about to increase.

Starting in July, Medicare beneficiaries may be able to get a GLP-1 prescription for weight loss for $50 a month. It’s a notable shift for Medicare, which has long been barred from covering weight loss treatments. The drugs, such as Wegovy and Zepbound, are effective but can be expensive without insurance coverage. They’re available in

You don't have permission to access "http://www.medpagetoday.com/publichealthpolicy/medicare/118333" on this server. Reference #18.61f4d517.1762408906.37911d7 https://errors.edgesuite.net/18.61f4d517.1762408906.37911d7

Share on PinterestResearch suggests that Medicare coverage of hormone therapy varies widely, depending on the purpose of the drug.Gender-affirming therapy and surgery can each have important positive effects on the quality of life for transgender individuals, as research has shown.Anecdotal evidence and nationwide surveys also support this conclusion.For example, according to a recent Trevor Project…